Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:52 PM
Ignite Modification Date:
2025-12-24 @ 11:52 PM
NCT ID:
NCT00850551
Eligibility Criteria:
Inclusion Criteria:
* Male or female at least 18 years old
* Confirmed diagnosis of cystic fibrosis
* Chronically colonization wtih Pseudomonas defined by positive sputum or lower airway cultures on 2 or more occasions in any 12 month period
* Ability to participate in an interview and administration of questionnaire lasting 60 minutes
* Clinically stable without IV antibiotic treatment for a pulmonary exacerbation in the prior 2 weeks
* Ability to perform spirometry
* Have a home telephone line or home computer with internet connection
* Written informed consent
Exclusion Criteria:
* Colonization with burkholderia cepacia complex
* Confirmed diagnosis of allergic bronchopulmonary aspergillosis as defined by the CFF guidance document
* Currently receiving antimicrobial therapy to treat non-tuberculous mycobacterium
* History of prior solid organ transplant
* Inability to speak and read the English language well enough to complete questionnaire
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00850551
Study Brief:
Protocol Section:
NCT00850551